Pharmacological LSD1 inhibition in combination with anti-proliferative cancer drugs might be a rational strategy for the treatment of lung adenocarcinoma to suppress tumor proliferation while preventing metastatic phenotype. The gene discussed is KDM1A; the disease is lung adenocarcinoma.